September 19, 2021 22:24 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Charanjit Singh Channi becomes new Punjab CM; appointment of two deputies likely | Hope Amarinder Singh works in interest of party: Ashok Gehlot | PM Modi urges citizens to take part in mementos auction | India records over 30,000 fresh COVID infections in last 24 hours | Rajasthan govt faces flak from opposition BJP after passing bill to register child marriages
Moderna's COVID vaccine approved by EU regulator for use on children aged 12-17 Moderna vaccine
Image Credit: Wikimedia Commons

Moderna's COVID vaccine approved by EU regulator for use on children aged 12-17

India Blooms News Service | @indiablooms | 23 Jul 2021, 11:24 pm

The Hague, Netherlands/ IBNS: Moderna's coronavirus vaccine has been approved by the European regulator for use on children aged 12 to 17, making it the second jab to be administered on adolescents in the continent.

"The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above," the European Medicines Agency (EMA) told media, using Moderna's brand name.

The vaccine will be given in two shots, each four weeks apart.

The decision by the Amsterdam-based agency follows the approval of the first vaccine for European youngsters, by Pfizer/BioNTech in May.

"The study showed that Spikevax produced a comparable antibody response in 12-17-year-olds to that seen in young adults aged 18 to 25 years," it said.

The EU on Thursday said 200 million Europeans have been fully vaccinated, more than half of the adult population.

However, it is still short of the 70 percent target it had set for the summer.